Syros Pharmaceuticals, Inc.
A biopharmaceutical company working to redefine the power of small molecules to control gene expression. The company is focused on developing treatments for cancer and diseases caused by single gene mutations, including myelodysplastic syndromes, acute myeloid leukemia, pancreatic cancer, and colorectal cancer. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 68 |
Founded | 2011 |
Financials | |
|---|---|
Market Capitalization | 160.37M |
Revenue | 6.98M |
Operating Income | -126.70M |
Operating Margin | -1814.88% |
Net Income | -144.49M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4897 / 5373 |
Sector : Healthcare | 937 / 1144 |
Industry : Biotechnology | 492 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3774 / 5565 |
Sector : Healthcare | 629 / 1182 |
Industry : Biotechnology | 326 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4962 / 5436 |
Sector : Healthcare | 985 / 1164 |
Industry : Biotechnology | 534 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4264 / 5330 |
Sector : Healthcare | 723 / 1174 |
Industry : Biotechnology | 313 / 667 |